Editor's Picks

American Strategic Investment Co. (NYSE: NYC) Q4 & Full-Year 2025 Earnings Preview

American Strategic Investment Co. (NYSE: NYC) Q4 & Full-Year 2025 Earnings Preview

Key Highlights:

  • Expected Results: Analysts anticipate an EPS of approximately -$1.72 and revenue of $14.39 million for Q4 2025, reflecting continued profitability pressures in a challenging Manhattan office market.
  • Liquidity and Leverage Concerns: The company shows very tight liquidity, with a quick ratio around 0.15 and current ratio near 1.10 (as of the most recent reported quarter). The debt-to-equity ratio stands at a high ~349%, indicating substantial leverage.
  • Recent Performance Context: In Q3 2025, NYC reported a one-time net income of ~$35.75 million driven by a non-cash gain on the disposition of 1140 Avenue of the Americas. However, core operations showed negative trends, including negative operating income and modest Adjusted EBITDA. Trailing twelve-month net income remains negative.

American Strategic Investment Co. (NYSE: NYC) is a real estate investment trust (REIT) primarily owning commercial properties in New York City. The company operates in a highly competitive Manhattan office market and has been actively managing its portfolio through asset sales and debt reduction efforts amid elevated vacancies and remote-work trends.

NYC is scheduled to release its Q4 2025 and full-year 2025 financial results on April 15, 2026 (before market open), with a conference call/webcast at 11:00 a.m. ET the same day. The release was recently rescheduled from earlier dates to allow additional time for year-end auditing and 10-K preparation with its new independent auditor.

Analyst Expectations for Q4 2025 Consensus estimates project:

  • EPS: -$1.72
  • Revenue: $14.39 million

These figures point to ongoing operational challenges typical for office-focused REITs in the current environment.

Stock and Valuation Snapshot (as of early April 2026)

  • Recent trading price: ~$8.06 – $8.29
  • Market capitalization: ~$21.5 – $22.8 million
  • 52-week range: $7.03 – $16.30
  • 50-day and 200-day moving averages: around $8.84
  • Trailing P/E ratio: negative (reflecting overall unprofitability on a TTM basis)

Financial Health Overview NYC maintains a highly leveraged balance sheet with total debt around $249 million. As of September 30, 2025 (latest detailed balance sheet available), cash stood at approximately $3.4 million, contributing to limited liquidity. The company has been executing asset sales (including the Q3 disposition that generated a large one-time gain) to reduce debt and improve its capital structure.

In Q3 2025, the company reported:

  • Net income attributable to common stockholders: $35.75 million (primarily due to the non-cash gain on property disposition)
  • Adjusted EBITDA: ~$1.9 million
  • Portfolio occupancy: ~80.9%

However, core metrics such as operating income have remained under pressure, and trailing twelve-month results show net losses. Gross profit and operating trends in recent periods have highlighted cost and revenue challenges in the portfolio.

Weiss Ratings has maintained a cautious “sell (d-)” rating, consistent with investor concerns over liquidity, high leverage, and the difficult New York City commercial real estate environment.

The upcoming Q4 and full-year 2025 report will be important for assessing progress on portfolio optimization, debt reduction, occupancy trends, and overall liquidity position heading into 2026.

Leave a comment

Your email address will not be published. Required fields are marked *